Boston Scientific has agreed to buy thrombectomy company Penumbra for about $15 billion in cash and stock in a deal that bolsters its cardiovascular portfolio.
Source link
Boston Scientific to Buy Penumbra for $15 Billion in Cash, Stock
Date:
More like thisRelated
Reba McEntire Pays Tribute to Dolly Parton After Her Death
Reba McEntire is remembering Dolly Parton with a heartfelt...
Officials Played Down Risks in Ohio Train Disaster, Residents Now Say
Newly released government documents raise questions about what the...
Immigrant dad of USS Lincoln sailor is released from ICE detention
The immigrant father of a sailor who is on...